Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125585752 | 12558575 | 2 | F | 20160612 | 20160818 | 20160714 | 20160826 | EXP | AT-AMGEN GMBH-AUTSP2016089073 | AMGEN | 3.00 | YR | C | M | Y | 13.60000 | KG | 20160826 | MD | AT | AT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125585752 | 12558575 | 1 | PS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 2 MG, UNK | U | 125031 | 2 | MG | UNKNOWN FORMULATION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125585752 | 12558575 | 1 | White blood cell count decreased |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125585752 | 12558575 | HO |
125585752 | 12558575 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125585752 | 12558575 | Agitation | |
125585752 | 12558575 | Body temperature increased | |
125585752 | 12558575 | Chills | |
125585752 | 12558575 | Crying | |
125585752 | 12558575 | General physical health deterioration | |
125585752 | 12558575 | Haematoma | |
125585752 | 12558575 | Skin discolouration | |
125585752 | 12558575 | White blood cell count decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125585752 | 12558575 | 1 | 20160612 | 0 |